Evidence map›Paper›PMID 37809908›Full record

ArticleHeliyon2023

Identification of m

Xianfeng Wang, Yicheng Mao, Hanlu Xu, Jiyang Chen, Xiao Chen

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Xianfeng WangDepartment of Orthopedics, Suzhou Hospital of Anhui Medical University, Suzhou, 234000, Anhui, China.
Yicheng MaoWenzhou Medical University, Wenzhou, 325000, Wenzhou, China.
Hanlu XuWenzhou Medical University, Wenzhou, 325000, Wenzhou, China.
Jiyang ChenWenzhou Medical University, Wenzhou, 325000, Wenzhou, China.
Xiao ChenDepartment of Orthopedics, Suzhou Hospital of Anhui Medical University, Suzhou, 234000, Anhui, China.
Wenzhou Medical University · CNAnhui Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The epigenetic regulator in cancer progression and immune response has been demonstrated recently. However, the potential implications of 5-methylcytosine (m Methods: The RNA sequence profile of 911 normal and 259 primary STS tissues were obtained from GTEx and TCGA databases, respectively. We systematically analyzed the m Results: Two distinct m Conclusion: This work showed that the m

Indexed as

Immune cell infiltrationm5C methylationPrognostic signatureSoft tissue sarcomaTumor microenvironment

Identifiers

PMID37809908
PMCPMC10558950
OpenAlexW4386349573

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.